Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, announced that the U.S. Food and Drug Administration has approved Katerzia Oral Suspension, 1 mg/mL, the first and only FDA-approved amlodipine oral suspension.
July 10, 2019
· 2 min read